Kaplan–Meier analysis clearly denoted that CDKN2A/B loss was significantly associated with shorter OS (median OS 11.6 months vs. 49.2 months, P < 0.001) in patients with ICC (Figure 5A), but not in all patients (Figure 5B). This evidence concerns the gene CDKN2A and intrahepatic cholangiocarcinoma.